Aridis Pharmaceuticals Inc (NASDAQ:ARDS)

1.12
Delayed Data
As of Jul 01
 +0.02 / +1.82%
Today’s Change
0.88
Today|||52-Week Range
7.69
-51.93%
Year-to-Date
Pfizer (PFE) Seeks FDA Nod for Its Oral Antiviral COVID Pill
Jul 01 / Zacks.com - Paid Partner Content
Global Blood (GBT) Initiates Phase II Study on SCD Candidate
Jun 30 / Zacks.com - Paid Partner Content
Here's Why Aridis Pharmaceuticals (ARDS) Looks Ripe for Bottom Fishing
Jul 01 / Zacks.com - Paid Partner Content
Sutro Biopharma (STRO) Up 50% on Cancer Treatment Collaboration
Jun 28 / Zacks.com - Paid Partner Content
Why Endo (ENDP) Stock Wilted After its Surge on Tuesday?
Jun 30 / Zacks.com - Paid Partner Content
BioMarin (BMRN) Gets CHMP Nod for Hemophilia Drug Roctavian
Jun 27 / Zacks.com - Paid Partner Content